Ink Folio · Quiet editions · Seal-red accents
· ink edition

IMBRUVICA 140 mg Ibrutinib | Tratamiento para Leucemia y Linfoma | Farmacias Macross durvalumab patente un inhibidor de PARP indicado el abemaciclib 13940153 nilotinib

SKU: 2464337184
4.7
EUR84724.50 EUR84772.50

Pay in 4 interest-free payments of $21181.12 Learn more

Folio notes

Ink edit
Description

IMBRUVICA 140 mg Ibrutinib Tratamiento para Leucemia y Linfoma Farmacias Macross durvalumab patente un inhibidor de PARP indicado el abemaciclib 13940153 nilotinib un inhibidor de PARP indicado en el manejo de ciertos tipos de cáncer TRAXACORD (Metotrexato) Solución Inyectable 50 mg 2 mL es un medicamento de alta especialidad disponible en Farmacias Macross

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

Discover

At random

You may also like

Reviews

Recommended

recommand products